10X Genomics Inc (TXG) Sector
Health Care

(Current) $44.21
-1.39 (-3.05%) Open Price: 45.56

10x Genomics Inc. is a biotechnology company that was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness in Pleasanton, California, USA. The company's mission is to enable the study of biology at a single-cell level, providing researchers with innovative tools to gain a deeper understanding of complex biological systems.

The company's technology is centered around single-cell genomics, which allows researchers to analyze individual cells' genetic information and gain insights into cell diversity, function, and interactions within tissues and organisms. This technology has revolutionized the field of genomics and has applications in various research areas, including cancer research, immunology, neuroscience, and developmental biology.

10x Genomics' main product is the Chromium System, a platform that enables the high-throughput analysis of single cells and their genomic information. The system uses a microfluidic approach to isolate and barcode individual cells, which are then sequenced to generate comprehensive single-cell genomic data. This data can be used to identify unique cell populations, characterize gene expression patterns, and study cellular interactions in various biological contexts.

The company is listed on the Nasdaq Stock Market under the ticker symbol "TXG." It went public on September 12, 2019, and has experienced significant growth and recognition in the biotechnology industry since then. 10x Genomics' innovative technology has garnered attention from researchers worldwide, leading to numerous scientific publications utilizing their products in groundbreaking studies.

In addition to its single-cell genomics platform, 10x Genomics also offers other products and solutions, such as spatial transcriptomics and immune profiling assays, further expanding its reach and impact in the genomics research field. The company continues to invest in research and development to improve its existing products and develop new technologies that contribute to advancing our understanding of biology and disease.

(03/01/24) $45.56
(03/04/24) $45.60
(03/04/24) (Qty.)542,031
(03/01/24) $45.23
(03/01/24) $46.86
(10/29/23) $33.79
(07/30/23) $63.57
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing